Xue, K., Ying, X., Bu, Z., Wu, A., Li, Z., Tang, L., . . . Ji, J. (2018). Oxaliplatin plus S-1 or capecitabine as neoadjuvant or adjuvant chemotherapy for locally advanced gastric cancer with D2 lymphadenectomy: 5-year follow-up results of a phase II−III randomized trial. Chin J Cancer Res.
Style de citation ChicagoXue, Kan, et al. "Oxaliplatin Plus S-1 or Capecitabine As Neoadjuvant or Adjuvant Chemotherapy for Locally Advanced Gastric Cancer With D2 Lymphadenectomy: 5-year Follow-up Results of a Phase II−III Randomized Trial." Chin J Cancer Res 2018.
Style de citation MLAXue, Kan, et al. "Oxaliplatin Plus S-1 or Capecitabine As Neoadjuvant or Adjuvant Chemotherapy for Locally Advanced Gastric Cancer With D2 Lymphadenectomy: 5-year Follow-up Results of a Phase II−III Randomized Trial." Chin J Cancer Res 2018.